List of Studies ( Metabolite:Ser-Ile-Asp)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003224 | AN005286 | The Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD0156 is a Potent Inhibitor of Plasmodium Phosphatidylinositol 4-Kinase and is an Attractive Candidate for Repositioning Against Malaria | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003388 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002078 | AN003390 | Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002024 | AN003294 | Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003277 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST002011 | AN003279 | The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Blood | Human | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Blood | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Cultured cells | Human | Malaria | Pennsylvania State University | LC-MS |
| ST001985 | AN003236 | Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001232 | AN002050 | Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST001149 | AN001896 | Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis | Cultured cells | Plasmodium falciparum | Malaria | Pennsylvania State University | LC-MS |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | LC-MS |
